Scar Management Market Forecast 2025-2035: Silicone-Based Products and Atrophic Scar Treatments Lead Global Scar Management Trends [Yahoo! Finance]
Sonoma Pharmaceuticals, Inc. (SNOA)
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.sonomapharma.com
Company Research
Source: Yahoo! Finance
Silicone gels and sprays remain dominant due to clinical efficacy, while atrophic scars, mainly from acne, are the most treated type. Hospitals are the top end-user segment, offering advanced scar therapies. North America currently leads the market, but Asia-Pacific is expected to show the fastest growth. Challenges include high treatment costs, but innovation in digital health and remote monitoring presents significant opportunities. Key players include Bayer AG, B. Braun, Molnlycke, and Stratpharma. Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Scar Management Market - A Global and Regional Analysis: Focus on Product, Scar Type, End User, and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global scar management market is experiencing steady growth, driven by rising incidences of skin-related conditions, increasing aesthetic concerns, advancements in dermatological treatments, and a growing number of surgical
Show less
Read more
Impact Snapshot
Event Time:
SNOA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNOA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNOA alerts
High impacting Sonoma Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SNOA
News
- Sonoma Pharmaceuticals (NASDAQ:SNOA) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA [Yahoo! Finance]Yahoo! Finance
SNOA
Sec Filings
- 11/4/25 - Form 10-Q
- 10/23/25 - Form 8-K
- 10/9/25 - Form 8-K
- SNOA's page on the SEC website